This week it’s all about bringing attention to psoriasis and psoriatic arthritis as we close in on World Psoriasis Day: Thursday, October 29th. For more than a decade, the International Federation of Psoriasis Associations have sought to raise awareness about psoriasis each year on this day.

The Covid-19 pandemic creates an extra layer of concern for oncology patients who are just starting, in the midst of, or wrapping up treatment. Early reports raised concern when they indicated that Covid-19 mortality rates … Psoriasis: Myth Vs. Fact Description: Learn some facts about this skin disease and dispel myths associated with it. Back Skyrizi’s Rise Description: Learn more about Skyrizi™, the latest FDA-approved treatment for moderate-to-severe psoriasis. Back

With November being Healthy Skin Month, it’s the perfect time to give some extra attention to issues facing those with psoriasis. There are nearly 7.5 million Americans living with the dry, scaly, painful patches of skin typical of psoriasis. The most likely areas affected by psoriasis include skin around joints, face, neck, trunk, arms, hands, […]

The U.S. Food and Drug Administration approved a new treatment option for psoriasis patients earlier this year: AbbVie’s Skyrizi (risankizumab-rzaa). This medication, which is used as a subcutaneous injection, gained this approval after a series of studies showed a high rate of skin clearance in adults with severe plaque psoriasis using Skyrizi. Ready for even […]

Scroll to Top